Feed Drop – Interview with Dan Agroskin

FEED DROP – Clinical Research Evolved

Noah and John talk with Dan Agroskin, a managing director at a leading private equity firm with a focus on the clinical research industry. We discuss how investments shape industries, what entrepreneurs should think about private equity, and the forces that drive exceptional business growth.

Find Out More
Dan Agroskin
Clinical Research Evolved
Noah Goodson, PhD
John Reites
Kyle Ricketts

About the Show
Life Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies, pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock market responds to biotech IPOs. Life Science Today also explores trends around clinical research, including the evolving patterns that determine how drugs and therapies are developed and approved. It’s news, with a dash of perspective, focused on the life science industry. 

Galapagos + CellPoint + AboundBio, Radius, Ipsen + Epizyme, DEM Bio

Double acquisition, private money, affordable deals, and a surprising $70M launch

Find out more at
https://LifeScienceTodayPodcast.com

Story References
Galapagos + CellPoint + AboundBio
Radius
Ipsen + Epizyme
DEM Bio

About the Show
Life Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies, pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock market responds to biotech IPOs. Life Science Today also explores trends around clinical research, including the evolving patterns that determine how drugs and therapies are developed and approved. It’s news, with a dash of perspective, focused on the life science industry. 

AbbVie, Third Rock, Scholar Rock, Kyowa Kirin

Crohn’s approval, new VC round, direct offerings, and potential asset sales.
 
Find out more at
https://LifeScienceTodayPodcast.com

Story References
AbbVie
Third Rock
Scholar Rock
Kyowa Kirin

About the Show
Life Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies, pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock market responds to biotech IPOs. Life Science Today also explores trends around clinical research, including the evolving patterns that determine how drugs and therapies are developed and approved. It’s news, with a dash of perspective, focused on the life science industry. 

BlueBird, FDA, Resilience, Corvia, Code, Mineralys, Tessa

Gene therapy, minor legislation, a $625M series D, and four companies raise $373M.

Find out more at
https://LifeScienceTodayPodcast.com

Story References
BlueBird
FDA
Resilience
Corvia, Code, Mineralys, Tessa

About the Show
Life Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies, pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock market responds to biotech IPOs. Life Science Today also explores trends around clinical research, including the evolving patterns that determine how drugs and therapies are developed and approved. It’s news, with a dash of perspective, focused on the life science industry. 

GSK + Affinivax, Pfizer – Haleon, Regeneron, Roche + Repare

Pharma buys, pharma splits, pharma trades, and oncology biobucks from pharma

Find out more at
https://LifeScienceTodayPodcast.com

Story References
GSK + Affinivax
Pfizer – Haleon
Regeneron
Roche + Repare

About the Show
Life Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies, pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock market responds to biotech IPOs. Life Science Today also explores trends around clinical research, including the evolving patterns that determine how drugs and therapies are developed and approved. It’s news, with a dash of perspective, focused on the life science industry. 

Chimex, Emergent, SIGA, Merck & Kelun, Inceptor, Laekna, Kriya

Pox progress, an oncology acquisition, and we look at $360M worth of biotech funding

Find out more at
https://LifeScienceTodayPodcast.com

Story References
Chimex, Emergent, SIGA
Merck & Kelun
Inceptor, Laekna, Kriya

About the Show
Life Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies, pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock market responds to biotech IPOs. Life Science Today also explores trends around clinical research, including the evolving patterns that determine how drugs and therapies are developed and approved. It’s news, with a dash of perspective, focused on the life science industry.